Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Bortezomib 179324-69-7

Bortezomib 179324-69-7

Inquiry

Post Date:	May 07,2019
Expiry Date:	Nov 03,2019
Detailed Description:	Cas No. :179324-69-7 Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.

CAS Registry Number:	179324-69-7
Synonyms:	;VELCADE;dpba;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide;N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide;Bortizomib;
Molecular Formula:	C₁₉H₂₅BN₄O₄
Molecular Weight:	384.2372
Molecular Structure:

Company:	Shanghai Neopharm Co., Ltd. [ China ]
Contact:	Carol Zhu
Tel:	021-58826758
Fax:	021-58827258
Email:	sales@neopharm.com.cn

Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.

潘金莲被吸乳揉到高潮的视频,久久99久久99精品免观看,在电影院里拨开内裤挺进,护士交换粗吟配乱大交动态图

Bortezomib 179324-69-7

Inquiry

179324-69-7